Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Acute Kidney Injury | 10 | 2019 | 1943 | 1.080 |
Why?
|
Trypanosomiasis, African | 4 | 2014 | 30 | 0.820 |
Why?
|
Variant Surface Glycoproteins, Trypanosoma | 2 | 2018 | 8 | 0.630 |
Why?
|
Antihypertensive Agents | 3 | 2018 | 2028 | 0.580 |
Why?
|
Antibodies, Protozoan | 2 | 2018 | 250 | 0.560 |
Why?
|
Trypanosoma congolense | 1 | 2014 | 3 | 0.470 |
Why?
|
Hypertrophy, Right Ventricular | 1 | 2015 | 109 | 0.460 |
Why?
|
Aorta, Abdominal | 5 | 2018 | 626 | 0.440 |
Why?
|
Renin-Angiotensin System | 1 | 2018 | 736 | 0.440 |
Why?
|
Cardiac Tamponade | 1 | 2015 | 175 | 0.430 |
Why?
|
Hypertension | 9 | 2018 | 8616 | 0.420 |
Why?
|
Reagent Kits, Diagnostic | 1 | 2014 | 238 | 0.420 |
Why?
|
Antigens, Protozoan | 2 | 2014 | 315 | 0.410 |
Why?
|
Pericardial Effusion | 1 | 2015 | 245 | 0.410 |
Why?
|
Cardiac Surgical Procedures | 2 | 2017 | 3682 | 0.390 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2018 | 1060 | 0.380 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2018 | 1513 | 0.380 |
Why?
|
Ibuprofen | 1 | 2013 | 228 | 0.380 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 4 | 2014 | 3801 | 0.370 |
Why?
|
Kidney Function Tests | 2 | 2017 | 684 | 0.360 |
Why?
|
Nephrolithiasis | 3 | 2017 | 117 | 0.360 |
Why?
|
Hypoglycemia | 1 | 2017 | 896 | 0.340 |
Why?
|
Oxygen Consumption | 1 | 2016 | 1872 | 0.330 |
Why?
|
Hyperglycemia | 1 | 2017 | 1389 | 0.310 |
Why?
|
Renal Replacement Therapy | 3 | 2019 | 282 | 0.290 |
Why?
|
Brain Diseases | 1 | 2016 | 1552 | 0.270 |
Why?
|
Nephrocalcinosis | 2 | 2017 | 51 | 0.270 |
Why?
|
Urogenital Abnormalities | 2 | 2020 | 255 | 0.270 |
Why?
|
Heart Arrest | 1 | 2016 | 1516 | 0.260 |
Why?
|
Blood Platelets | 1 | 2016 | 2464 | 0.240 |
Why?
|
Tissue Expansion Devices | 2 | 2018 | 159 | 0.230 |
Why?
|
Critical Care | 1 | 2017 | 2714 | 0.230 |
Why?
|
Proteinuria | 3 | 2013 | 606 | 0.220 |
Why?
|
Hypertension, Pulmonary | 1 | 2015 | 1604 | 0.220 |
Why?
|
Proteomics | 2 | 2014 | 3907 | 0.220 |
Why?
|
Cystic Fibrosis | 1 | 2013 | 1284 | 0.220 |
Why?
|
Nephrotic Syndrome | 2 | 2017 | 380 | 0.220 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 2 | 2016 | 254 | 0.210 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2271 | 0.210 |
Why?
|
Blood Glucose | 1 | 2017 | 6421 | 0.200 |
Why?
|
Mitochondria | 1 | 2016 | 3672 | 0.200 |
Why?
|
Foramen Ovale, Patent | 2 | 2014 | 209 | 0.190 |
Why?
|
Arterial Occlusive Diseases | 2 | 2018 | 742 | 0.190 |
Why?
|
Fibrinolytic Agents | 3 | 2017 | 2077 | 0.190 |
Why?
|
Child, Preschool | 18 | 2020 | 42511 | 0.180 |
Why?
|
Trypanosoma brucei brucei | 2 | 2018 | 43 | 0.180 |
Why?
|
Pedigree | 5 | 2020 | 4535 | 0.180 |
Why?
|
Postoperative Complications | 3 | 2019 | 15808 | 0.170 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 2020 | 67 | 0.170 |
Why?
|
Aortic Valve Stenosis | 3 | 2018 | 2022 | 0.170 |
Why?
|
Urinary Tract | 2 | 2020 | 305 | 0.170 |
Why?
|
Child | 18 | 2020 | 80573 | 0.160 |
Why?
|
Water-Electrolyte Imbalance | 1 | 2019 | 110 | 0.150 |
Why?
|
Renal Artery | 2 | 2017 | 355 | 0.150 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2019 | 193 | 0.150 |
Why?
|
Mesenteric Arteries | 1 | 2018 | 177 | 0.150 |
Why?
|
Glomerular Filtration Rate | 2 | 2020 | 2232 | 0.140 |
Why?
|
Aortic Diseases | 2 | 2013 | 741 | 0.140 |
Why?
|
Receptors, Virus | 2 | 2013 | 651 | 0.140 |
Why?
|
Mutation | 6 | 2020 | 30209 | 0.140 |
Why?
|
Kidney Diseases | 1 | 2008 | 2100 | 0.140 |
Why?
|
Intensive Care Units, Pediatric | 3 | 2019 | 1021 | 0.140 |
Why?
|
Septal Occluder Device | 2 | 2014 | 126 | 0.130 |
Why?
|
Neurofibromin 1 | 1 | 2018 | 190 | 0.130 |
Why?
|
Blood Pressure | 3 | 2017 | 8532 | 0.130 |
Why?
|
Feedback, Physiological | 1 | 2018 | 480 | 0.130 |
Why?
|
Anion Transport Proteins | 1 | 2016 | 141 | 0.120 |
Why?
|
Cell Respiration | 1 | 2016 | 197 | 0.120 |
Why?
|
Trypanocidal Agents | 1 | 2014 | 40 | 0.120 |
Why?
|
Vesico-Ureteral Reflux | 1 | 2018 | 433 | 0.120 |
Why?
|
Genetic Markers | 2 | 2017 | 2603 | 0.120 |
Why?
|
Adolescent | 17 | 2020 | 88819 | 0.110 |
Why?
|
Cattle Diseases | 1 | 2014 | 50 | 0.110 |
Why?
|
Creatinine | 1 | 2020 | 1916 | 0.110 |
Why?
|
Neurofibromatoses | 1 | 2018 | 303 | 0.110 |
Why?
|
Infant | 12 | 2020 | 36427 | 0.110 |
Why?
|
Organogenesis | 1 | 2015 | 213 | 0.110 |
Why?
|
Blood Pressure Determination | 1 | 2017 | 646 | 0.110 |
Why?
|
Forkhead Transcription Factors | 1 | 2020 | 1623 | 0.100 |
Why?
|
Humans | 43 | 2021 | 766117 | 0.100 |
Why?
|
Kidney | 3 | 2020 | 7072 | 0.100 |
Why?
|
Acyltransferases | 1 | 2014 | 305 | 0.100 |
Why?
|
Insulin-Like Growth Factor Binding Protein 3 | 1 | 2014 | 416 | 0.100 |
Why?
|
DNA Mutational Analysis | 2 | 2017 | 4112 | 0.100 |
Why?
|
Mesentery | 1 | 2013 | 200 | 0.100 |
Why?
|
Referral and Consultation | 2 | 2016 | 3617 | 0.100 |
Why?
|
Office Visits | 1 | 2016 | 594 | 0.100 |
Why?
|
Endovascular Procedures | 2 | 2018 | 2218 | 0.100 |
Why?
|
Tissue Plasminogen Activator | 1 | 2017 | 1164 | 0.090 |
Why?
|
Heart Defects, Congenital | 2 | 2019 | 4712 | 0.090 |
Why?
|
Tissue Expansion | 1 | 2012 | 163 | 0.090 |
Why?
|
Resuscitation | 1 | 2016 | 681 | 0.090 |
Why?
|
Africa South of the Sahara | 1 | 2014 | 751 | 0.090 |
Why?
|
Stroke | 3 | 2021 | 9748 | 0.090 |
Why?
|
Syndrome | 4 | 2018 | 3270 | 0.090 |
Why?
|
Thrombotic Microangiopathies | 1 | 2012 | 125 | 0.090 |
Why?
|
Aortic Coarctation | 1 | 2012 | 278 | 0.090 |
Why?
|
Anticoagulants | 2 | 2017 | 4857 | 0.090 |
Why?
|
Heparin | 1 | 2017 | 1635 | 0.080 |
Why?
|
Membrane Glycoproteins | 2 | 2013 | 3692 | 0.080 |
Why?
|
Random Allocation | 1 | 2014 | 2395 | 0.080 |
Why?
|
Monitoring, Physiologic | 1 | 2017 | 1794 | 0.080 |
Why?
|
Repressor Proteins | 1 | 2020 | 2974 | 0.080 |
Why?
|
Treatment Outcome | 7 | 2018 | 65219 | 0.080 |
Why?
|
Image Enhancement | 1 | 2020 | 2857 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 4 | 2018 | 18076 | 0.080 |
Why?
|
Ischemic Attack, Transient | 1 | 2014 | 871 | 0.080 |
Why?
|
Organoids | 1 | 2015 | 740 | 0.080 |
Why?
|
Cloning, Molecular | 1 | 2014 | 4163 | 0.080 |
Why?
|
Apolipoproteins E | 1 | 2014 | 1459 | 0.080 |
Why?
|
Hospital Mortality | 2 | 2019 | 5340 | 0.080 |
Why?
|
Cattle | 1 | 2014 | 3801 | 0.080 |
Why?
|
Thrombolytic Therapy | 1 | 2017 | 2051 | 0.080 |
Why?
|
Drug Therapy, Combination | 1 | 2018 | 6309 | 0.080 |
Why?
|
Hospital Costs | 1 | 2014 | 955 | 0.080 |
Why?
|
Pluripotent Stem Cells | 1 | 2015 | 808 | 0.070 |
Why?
|
Heredity | 2 | 2017 | 149 | 0.070 |
Why?
|
Sensitivity and Specificity | 4 | 2018 | 14645 | 0.070 |
Why?
|
Male | 24 | 2020 | 363935 | 0.070 |
Why?
|
Lipocalins | 1 | 2008 | 162 | 0.070 |
Why?
|
Epigenesis, Genetic | 1 | 2020 | 3818 | 0.070 |
Why?
|
Acute-Phase Proteins | 1 | 2008 | 252 | 0.070 |
Why?
|
Contrast Media | 1 | 2020 | 5330 | 0.070 |
Why?
|
Interleukin-18 | 1 | 2008 | 251 | 0.060 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2008 | 291 | 0.060 |
Why?
|
Female | 24 | 2020 | 396233 | 0.060 |
Why?
|
Swine | 1 | 2016 | 5986 | 0.060 |
Why?
|
Molecular Weight | 1 | 2008 | 2161 | 0.060 |
Why?
|
Mice, Inbred BALB C | 1 | 2014 | 6215 | 0.060 |
Why?
|
Aorta | 1 | 2013 | 2040 | 0.060 |
Why?
|
Animals | 9 | 2020 | 168800 | 0.060 |
Why?
|
Drug Administration Schedule | 1 | 2013 | 4853 | 0.060 |
Why?
|
Energy Metabolism | 1 | 2016 | 2894 | 0.060 |
Why?
|
Sulfonamides | 1 | 2014 | 1980 | 0.060 |
Why?
|
Retrospective Studies | 10 | 2019 | 81565 | 0.060 |
Why?
|
Vascular Surgical Procedures | 1 | 2013 | 1506 | 0.060 |
Why?
|
Glycosylation | 2 | 2018 | 1099 | 0.060 |
Why?
|
Genetic Association Studies | 3 | 2018 | 2744 | 0.060 |
Why?
|
Pyrazoles | 1 | 2014 | 2031 | 0.060 |
Why?
|
Albuminuria | 1 | 2008 | 659 | 0.060 |
Why?
|
Thrombosis | 1 | 2017 | 2955 | 0.050 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9601 | 0.050 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2014 | 2768 | 0.050 |
Why?
|
Escherichia coli | 1 | 2014 | 4210 | 0.050 |
Why?
|
Risk Factors | 6 | 2019 | 74857 | 0.050 |
Why?
|
Age Factors | 1 | 2018 | 18386 | 0.050 |
Why?
|
Gene Expression | 1 | 2014 | 7582 | 0.050 |
Why?
|
ROC Curve | 3 | 2016 | 3614 | 0.050 |
Why?
|
Pediatrics | 1 | 2016 | 3609 | 0.050 |
Why?
|
Neoplasm Proteins | 1 | 2013 | 3594 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2013 | 10737 | 0.040 |
Why?
|
Transcription Factors | 1 | 2020 | 12130 | 0.040 |
Why?
|
Amphibian Proteins | 1 | 2020 | 35 | 0.040 |
Why?
|
Prognosis | 6 | 2018 | 29912 | 0.040 |
Why?
|
Age of Onset | 2 | 2017 | 3344 | 0.040 |
Why?
|
Predictive Value of Tests | 4 | 2017 | 15403 | 0.040 |
Why?
|
Adult | 9 | 2018 | 223139 | 0.040 |
Why?
|
Electronic Health Records | 1 | 2017 | 4863 | 0.040 |
Why?
|
Young Adult | 6 | 2017 | 59868 | 0.040 |
Why?
|
Pilot Projects | 1 | 2013 | 8724 | 0.040 |
Why?
|
Infant, Newborn | 2 | 2017 | 26381 | 0.040 |
Why?
|
Heart Diseases | 1 | 2012 | 2818 | 0.040 |
Why?
|
Protein Conformation | 2 | 2018 | 3946 | 0.040 |
Why?
|
Constriction, Pathologic | 2 | 2013 | 1102 | 0.040 |
Why?
|
Prosthesis Design | 2 | 2018 | 2111 | 0.040 |
Why?
|
Area Under Curve | 2 | 2016 | 1638 | 0.040 |
Why?
|
Larva | 1 | 2020 | 511 | 0.040 |
Why?
|
Xenopus | 1 | 2020 | 709 | 0.040 |
Why?
|
Diagnostic Imaging | 1 | 2012 | 3530 | 0.040 |
Why?
|
Kidney Transplantation | 1 | 2013 | 4277 | 0.040 |
Why?
|
Cohort Studies | 3 | 2018 | 41684 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2012 | 2306 | 0.040 |
Why?
|
Acute Disease | 1 | 2008 | 7237 | 0.030 |
Why?
|
Collateral Circulation | 1 | 2018 | 289 | 0.030 |
Why?
|
Duffy Blood-Group System | 1 | 1997 | 61 | 0.030 |
Why?
|
Phenotype | 4 | 2018 | 16716 | 0.030 |
Why?
|
Disease Models, Animal | 1 | 2016 | 18321 | 0.030 |
Why?
|
Lung | 1 | 2015 | 10063 | 0.030 |
Why?
|
Aortography | 1 | 2018 | 423 | 0.030 |
Why?
|
Radionuclide Imaging | 1 | 2020 | 1985 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2008 | 4521 | 0.030 |
Why?
|
Trypanosoma brucei gambiense | 1 | 2014 | 7 | 0.030 |
Why?
|
Bicarbonates | 1 | 2016 | 293 | 0.030 |
Why?
|
Agglutination Tests | 1 | 2014 | 43 | 0.030 |
Why?
|
Sulfates | 1 | 2016 | 375 | 0.030 |
Why?
|
Mice | 4 | 2020 | 81839 | 0.030 |
Why?
|
Regional Blood Flow | 1 | 2018 | 1479 | 0.030 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2017 | 3665 | 0.030 |
Why?
|
Validation Studies as Topic | 1 | 2014 | 162 | 0.030 |
Why?
|
Endoderm | 1 | 2015 | 165 | 0.030 |
Why?
|
Anastomosis, Surgical | 1 | 2018 | 992 | 0.030 |
Why?
|
Inhibitory Concentration 50 | 1 | 2014 | 463 | 0.030 |
Why?
|
Crystallography, X-Ray | 1 | 2018 | 1947 | 0.030 |
Why?
|
Heterozygote | 1 | 2020 | 2796 | 0.030 |
Why?
|
Vitamin D-Binding Protein | 1 | 2014 | 129 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2270 | 0.030 |
Why?
|
Spheroids, Cellular | 1 | 2015 | 329 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2015 | 683 | 0.030 |
Why?
|
Transplantation, Autologous | 1 | 2018 | 2125 | 0.030 |
Why?
|
Odds Ratio | 2 | 2016 | 9657 | 0.030 |
Why?
|
Immunoblotting | 1 | 2016 | 1644 | 0.030 |
Why?
|
Mesenteric Artery, Superior | 1 | 2013 | 96 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 1 | 2020 | 36548 | 0.020 |
Why?
|
Protein Folding | 1 | 2016 | 868 | 0.020 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2016 | 2743 | 0.020 |
Why?
|
Combined Modality Therapy | 2 | 2014 | 8525 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2016 | 2469 | 0.020 |
Why?
|
Cost-Benefit Analysis | 2 | 2014 | 5531 | 0.020 |
Why?
|
Hypertrophy, Left Ventricular | 1 | 2016 | 855 | 0.020 |
Why?
|
Aminopyridines | 1 | 2014 | 576 | 0.020 |
Why?
|
Protein Transport | 1 | 2016 | 1939 | 0.020 |
Why?
|
Angioplasty | 1 | 2013 | 353 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2020 | 2702 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2016 | 3432 | 0.020 |
Why?
|
Binding Sites | 1 | 2018 | 6001 | 0.020 |
Why?
|
Family | 1 | 2020 | 3208 | 0.020 |
Why?
|
Reproducibility of Results | 2 | 2020 | 20137 | 0.020 |
Why?
|
Time Factors | 3 | 2018 | 40108 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2014 | 1130 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2014 | 3051 | 0.020 |
Why?
|
Microscopy, Confocal | 1 | 2015 | 1967 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2020 | 5300 | 0.020 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2019 | 1480 | 0.020 |
Why?
|
Models, Molecular | 1 | 2018 | 5382 | 0.020 |
Why?
|
Protein Binding | 1 | 2020 | 9301 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 2014 | 1036 | 0.020 |
Why?
|
Embryonic Stem Cells | 1 | 2015 | 1242 | 0.020 |
Why?
|
Erythrocytes | 1 | 1997 | 2394 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 4565 | 0.020 |
Why?
|
Nephrectomy | 1 | 2013 | 928 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2015 | 1651 | 0.020 |
Why?
|
Central Nervous System | 1 | 2014 | 1343 | 0.020 |
Why?
|
Risk Assessment | 2 | 2019 | 24276 | 0.020 |
Why?
|
Critical Illness | 1 | 2019 | 2749 | 0.020 |
Why?
|
Genotype | 2 | 2017 | 13028 | 0.020 |
Why?
|
Brain Mapping | 1 | 2021 | 6595 | 0.020 |
Why?
|
Length of Stay | 1 | 2019 | 6490 | 0.020 |
Why?
|
Severity of Illness Index | 2 | 2014 | 15882 | 0.020 |
Why?
|
Tissue Engineering | 1 | 2015 | 1857 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2020 | 14456 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2018 | 39243 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2016 | 13400 | 0.010 |
Why?
|
Ultrasonography | 1 | 2017 | 5988 | 0.010 |
Why?
|
Transplantation, Homologous | 1 | 2013 | 4860 | 0.010 |
Why?
|
Induced Pluripotent Stem Cells | 1 | 2015 | 1884 | 0.010 |
Why?
|
Genetic Variation | 1 | 2018 | 6612 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12061 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2013 | 6506 | 0.010 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2008 | 1331 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2020 | 22228 | 0.010 |
Why?
|
Middle Aged | 5 | 2014 | 223083 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8494 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13273 | 0.010 |
Why?
|
Cell Line | 1 | 2015 | 15546 | 0.010 |
Why?
|
United States | 2 | 2019 | 72920 | 0.010 |
Why?
|
Disease Progression | 1 | 2017 | 13616 | 0.010 |
Why?
|
Boston | 1 | 2013 | 9335 | 0.010 |
Why?
|
Incidence | 1 | 2018 | 21513 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 18967 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2015 | 9527 | 0.010 |
Why?
|
Prevalence | 1 | 2016 | 15827 | 0.010 |
Why?
|
Serology | 1 | 1997 | 7 | 0.010 |
Why?
|
Cell Differentiation | 1 | 2015 | 11642 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2014 | 10380 | 0.010 |
Why?
|
Polymorphism, Restriction Fragment Length | 1 | 1997 | 765 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54812 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2017 | 20700 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2008 | 8038 | 0.010 |
Why?
|
Aged | 2 | 2014 | 171219 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1997 | 6059 | 0.000 |
Why?
|